Search results | NICE

158 results

Sorted by Relevance . Sort by Date

Guidance Remove Guidance filter
Diagnostics guidance Remove Diagnostics guidance filter
Social care guidelines Remove Social care guidelines filter
Highly specialised technologies guidance Remove Highly specialised technologies guidance filter
Antimicrobial prescribing guidelines Remove Antimicrobial prescribing guidelines filter
Quality standards Remove Quality standards filter

Myocardial infarction (acute): Early rule out using high-sensitivity troponin tests (Elecsys Troponin T high-sensitive, ARCHITECT STAT High Sensitive Troponin-I and AccuTnI+3 assays) (DG15)

This guidance has been updated and replaced by NICE diagnostics guidance 40.

Type

Diagnostics guidance

Published

01 October 2014
Elucigene FH20 and LIPOchip for the diagnosis of familial hypercholesterolaemia (DG2)

Both index tests included in this guidance are no longer commercially available. Therefore the guidance has been withdrawn.

Type

Diagnostics guidance

Published

14 December 2011
Diagnosing prostate cancer: PROGENSA PCA3 assay and Prostate Health Index (DG17)

This guideline has been updated and replaced by NICE guideline NG131.

Type

Diagnostics guidance

Published

03 June 2015
Gene expression profiling and expanded immunohistochemistry tests for guiding adjuvant chemotherapy decisions in early breast cancer management: MammaPrint, Oncotype DX, IHC4 and Mammostrat (DG10)

This guidance has been updated and replaced by NICE diagnostics guidance 34.

Type

Diagnostics guidance

Published

25 September 2013
Adjunctive colposcopy technologies for examination of the uterine cervix – DySIS and the Niris Imaging System (DG4)

This guidance has been updated and replaced by NICE diagnostics guidance 32.

Type

Diagnostics guidance

Published

01 August 2012
Xpert MTB/RIF assay for the detection of active pulmonary tuberculosis and multi-drug resistant tuberculosis

In development [GID-DT9] Expected publication date: TBC

Type

Diagnostics guidance

Status

In development
KRAS mutation testing of tumours in adults with metastatic colorectal cancer (discontinued)

In development [GID-DT14] Expected publication date: TBC

Type

Diagnostics guidance

Status

In development
Multiple myeloma and related disorders - Freelite assays (and alternative technologies identified during scoping) for diagnosis in primary care

In development [GID-DT28] Expected publication date: TBC

Type

Diagnostics guidance

Status

In development